Try our Advanced Search for more refined results
September 15, 2011
GLYNN et al v. MERCK SHARP & DOHME CORP.
Case Number:
3:11-cv-05304
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 02, 2013
Fosamax Ruling Puts Preemption In Play For Branded Drugs
A New Jersey federal judge's ruling Thursday that claims related to Merck & Co. Inc.'s Fosamax are preempted by federal law will likely inspire other brand-name drug makers to mount the defense, which companies have forsaken following an unfavorable U.S. Supreme Court decision four years ago.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login